ES2646813T3 - Un dispositivo para el cuidado de heridas - Google Patents

Un dispositivo para el cuidado de heridas Download PDF

Info

Publication number
ES2646813T3
ES2646813T3 ES10179829.6T ES10179829T ES2646813T3 ES 2646813 T3 ES2646813 T3 ES 2646813T3 ES 10179829 T ES10179829 T ES 10179829T ES 2646813 T3 ES2646813 T3 ES 2646813T3
Authority
ES
Spain
Prior art keywords
wound
agent
systemic
analgesic agent
care device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES10179829.6T
Other languages
English (en)
Inventor
Gitte Juel Friis
Truels Sterm Larsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coloplast AS
Original Assignee
Coloplast AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coloplast AS filed Critical Coloplast AS
Application granted granted Critical
Publication of ES2646813T3 publication Critical patent/ES2646813T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41Anti-inflammatory agents, e.g. NSAIDs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Un dispositivo para el cuidado de heridas para el tratamiento local del dolor en una herida, comprendiendo dicho dispositivo una capa o película impermeable al agua y un adhesivo respetuoso con la piel en el que se incorpora un constituyente o elemento absorbente, el dispositivo comprende una capa de contacto con la herida relativamente fina que incorpora un agente analgésico que se libera a la herida de tal manera que no se puede encontrar una concentración plasmática sistémica eficaz del agente analgésico y en la que el agente analgésico está presente en una cantidad inferior al 75 % del valor más bajo recomendado para la dosis unitaria diaria sistémica para el tratamiento sistémico usando el agente.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11

Claims (1)

  1. imagen1
ES10179829.6T 2003-06-19 2004-06-18 Un dispositivo para el cuidado de heridas Expired - Lifetime ES2646813T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300920 2003-06-19
DK200300920 2003-06-19

Publications (1)

Publication Number Publication Date
ES2646813T3 true ES2646813T3 (es) 2017-12-18

Family

ID=33547541

Family Applications (2)

Application Number Title Priority Date Filing Date
ES10179829.6T Expired - Lifetime ES2646813T3 (es) 2003-06-19 2004-06-18 Un dispositivo para el cuidado de heridas
ES04737034.1T Expired - Lifetime ES2602179T3 (es) 2003-06-19 2004-06-18 Un dispositivo para el cuidado de heridas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES04737034.1T Expired - Lifetime ES2602179T3 (es) 2003-06-19 2004-06-18 Un dispositivo para el cuidado de heridas

Country Status (8)

Country Link
US (2) US8039017B2 (es)
EP (2) EP2279763B1 (es)
JP (1) JP2006527705A (es)
CN (1) CN1829542A (es)
AU (1) AU2004246757B2 (es)
CA (1) CA2526751A1 (es)
ES (2) ES2646813T3 (es)
WO (1) WO2004110511A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006527705A (ja) * 2003-06-19 2006-12-07 コロプラスト アクティーゼルスカブ 創傷ケアデバイス
ES2541483T3 (es) * 2009-12-16 2015-07-21 Shasun Pharmaceuticals Limited Composición de hidrogel transdérmico de dexibuprofeno
FR2956322A1 (fr) * 2010-02-17 2011-08-19 Urgo Lab Utilisation d'oligosaccharides polysulfates synthetiques comme agents de detersion d'une plaie.
CN102946936B (zh) 2010-03-30 2016-05-04 火花医学研究有限公司 药物释放医用导管、管和装置
EP2734243A1 (en) * 2011-07-20 2014-05-28 3M Innovative Properties Company Dressing with ion-carrying composition
CN105209084B (zh) 2013-03-13 2018-07-03 艾利丹尼森公司 改善的粘合性能
US12447051B2 (en) 2020-08-24 2025-10-21 University Of Utah Research Foundation Multi-functional analgesic-releasing wound dressing

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576522A (en) * 1977-05-24 1980-10-08 Colorplast International A S Sealing material for ostomy devices
DK147035C (da) 1980-12-05 1984-09-03 Coloplast As Hudplade
SE455466C (sv) * 1986-03-10 1993-07-05 Moelnlycke Ab Foerband foer vaetskande saar
US5340363A (en) * 1986-03-10 1994-08-23 Molnlycke Ab Wound dressing
DK157899C (da) * 1987-12-15 1990-09-03 Coloplast As Hudpladeprodukt
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
CN2046383U (zh) 1989-05-06 1989-10-25 刘崇敬 中药止血绷带
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
DK5492A (da) * 1992-01-17 1993-07-18 Coloplast As Hudpladeprodukt
EP0560014A1 (en) * 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US6048850A (en) * 1992-09-22 2000-04-11 Young; Donald A. Method of inhibiting prostaglandin synthesis in a human host
DK169711B1 (da) * 1993-01-15 1995-01-23 Coloplast As Hudpladeprodukt
EP0695179A1 (en) 1993-04-22 1996-02-07 Minnesota Mining And Manufacturing Company Transdermal antiinflammatory composition
JP4259610B2 (ja) * 1994-04-08 2009-04-30 キューエルティー・ユーエスエイ・インコーポレーテッド 液体デリバリー組成物
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19503336C2 (de) 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Arzneiform zur Abgabe von Wirkstoffen an Wunden, Verfahren zu ihrer Herstellung und ihre Verwendung
JP3471122B2 (ja) * 1995-04-26 2003-11-25 アルケア株式会社 医療用粘着配合物
GB2311027B (en) * 1996-03-15 1999-10-27 Johnson & Johnson Medical Coated bioabsorbable beads for wound treatment
KR100213465B1 (ko) * 1996-11-01 1999-08-02 최좌진 케토프로펜 패취 조성물
AU4941297A (en) * 1996-11-15 1998-06-10 Dumex-Alpharma A/S A method for promoting tissue repair
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
US6500539B1 (en) * 1998-03-05 2002-12-31 The Regents Of The University Of California Anti-adhesion cellulose acetate wound dressing
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US6312713B1 (en) * 1998-06-12 2001-11-06 Bernard Korol Polymer matrices for storage and sustained release of drugs and chemicals
DE19830649C2 (de) * 1998-07-09 2003-04-10 Lohmann Therapie Syst Lts Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe
ES2252962T5 (es) 1998-08-06 2017-06-21 Jörg Dr.Dr. Schierholz Productos medicinales con actividad farmacológica retardada, y procedimiento para su preparación
FR2783412B1 (fr) * 1998-09-18 2000-12-15 Lhd Lab Hygiene Dietetique Compresse non adherente sterile
US6313370B1 (en) * 1999-04-29 2001-11-06 Morton Hyson Medicated wrap
CA2345779A1 (en) * 1999-08-27 2001-03-08 Department Of National Defence Hydrogel wound dressing containing liposome-encapsulated therapeutic agent
US6471986B1 (en) 2000-07-31 2002-10-29 Schering Plough Healthcare Products, Inc. Corn, callus and wart removing pads
ES2331302T3 (es) * 2001-05-01 2009-12-29 A.V. Topchiev Institute Of Petrochemical Synthesis Composiciones de hidrogel.
US8790688B2 (en) 2001-12-21 2014-07-29 Coloplast A/S Wound care device for local treatment of pain in a wound
JP2006527705A (ja) * 2003-06-19 2006-12-07 コロプラスト アクティーゼルスカブ 創傷ケアデバイス
US20070009583A1 (en) * 2003-10-10 2007-01-11 Qvist Michael H Dressing
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

Also Published As

Publication number Publication date
EP1633408B1 (en) 2016-08-17
WO2004110511A1 (en) 2004-12-23
ES2602179T3 (es) 2017-02-20
JP2006527705A (ja) 2006-12-07
US8039017B2 (en) 2011-10-18
EP1633408A1 (en) 2006-03-15
US20120064146A1 (en) 2012-03-15
US20070059348A1 (en) 2007-03-15
EP2279763A1 (en) 2011-02-02
CA2526751A1 (en) 2004-12-23
EP2279763B1 (en) 2017-08-09
CN1829542A (zh) 2006-09-06
AU2004246757A1 (en) 2004-12-23
AU2004246757B2 (en) 2009-01-08
US8409610B2 (en) 2013-04-02

Similar Documents

Publication Publication Date Title
CL2014001029A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion extendida que comprende una formulacion matricial que comprende un agente activo en forma de comprimido o multiparticulado; agente activo es un analgesico opioide; y uso en el tratamiento del dolor. (div. sol. 499-2012).
ES2545205T3 (es) Combinación de azelastina y ciclesonida
ES2543977T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
TW492882B (en) Cholinergic antagonist plaster composition
ES2498095T3 (es) Composición farmacéutica que comprende fentanil para el tratamiento del cáncer o el dolor intercurrente o agudo mediante administración sublingual
ATE430557T1 (de) Liposomen
DE60212847D1 (de) Topisch anwendbare arzneimittelformulierung
ES2646813T3 (es) Un dispositivo para el cuidado de heridas
CO5150154A1 (es) Composicion de sustrato y metodo para usarlo para el secuestro de irritantes de la piel
EA200600598A1 (ru) Лекарственные формы замедленного высвобождения
AR099567A2 (es) Formulación de tableta revestida que comprende saxagliptina y método de preparación
CL2004000851A1 (es) Composicion farmaceutica que comprende un antagonista opioide disperso en un material hidrofobico, un segundo material hidrofobico y un tercer material hidrofobico que contiene un agonista opioide, util para el tratamiento del dolor.
AR090677A2 (es) Preparacion farmaceutica que contiene oxicodona y naloxona
BR0107869A (pt) Composições farmacêuticas eletrogiradas
MX9301358A (es) Composicion topica para aliviar molestias y dolores.
ES2524369T3 (es) Unidad de dosificación que incluye un análogo de prostaglandina para el tratamiento del estreñimiento
ES2487496T3 (es) Agente para aliviar el síndrome metabólico
ATE339224T1 (de) Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung
GT200300247A (es) Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa-2
PL402550A1 (pl) Dopochwowe kompozycje farmaceutyczne oraz zastosowanie zródla nadtlenku i bioadhezyjnego nosnika
IT1319210B1 (it) Pellicola per la somministrazione dermica e transdermica di principiattivi.
AR036877A1 (es) Formulacion farmaceutica
DK1455849T3 (da) Sårbehandlingsanordning
JP2005021309A (ja) 痒み治療用冷却シート
JP2009256231A (ja) 芳香貼付部材